<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP07737319B8W1" file="EP07737319W1B8.xml" lang="en" country="EP" doc-number="2005954" kind="B8" correction-code="W1" date-publ="20121128" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................</B001EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>2005954</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20121128</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>07737319.9</B210><B220><date>20070222</date></B220><B240><B241><date>20081023</date></B241><B242><date>20091005</date></B242></B240><B250>ja</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>2006080691</B310><B320><date>20060323</date></B320><B330><ctry>JP</ctry></B330><B310>2007032777</B310><B320><date>20070213</date></B320><B330><ctry>JP</ctry></B330></B300><B400><B405><date>20121128</date><bnum>201248</bnum></B405><B430><date>20081224</date><bnum>200852</bnum></B430><B450><date>20121024</date><bnum>201243</bnum></B450><B452EP><date>20120530</date></B452EP><B480><date>20121128</date><bnum>201248</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/196       20060101AFI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/198       20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  31/20        20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  31/337       20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K  31/513       20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61K  31/53        20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>A61K  31/573       20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>A61K  31/704       20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>A61K  33/36        20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="10"><text>A61P  35/00        20060101ALI20071009BHEP        </text></classification-ipcr><classification-ipcr sequence="11"><text>A61P  43/00        20060101ALI20071009BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>KIT FÜR DIE KREBSTHERAPIE UND PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR KREBSTHERAPIE</B542><B541>en</B541><B542>KIT FOR CANCER THERAPY AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY</B542><B541>fr</B541><B542>KIT POUR LA THÉRAPIE DU CANCER ET COMPOSITION PHARMACEUTIQUE POUR LA THÉRAPIE DU CANCER</B542></B540><B560><B561><text>EP-A- 0 396 184</text></B561><B561><text>WO-A2-2004/093856</text></B561><B561><text>WO-A2-2005/027842</text></B561><B561><text>WO-A2-2005/039490</text></B561><B561><text>JP-A- 07 215 882</text></B561><B561><text>JP-A- 11 012 175</text></B561><B561><text>JP-A- 2000 506 489</text></B561><B561><text>JP-A- 2004 528 316</text></B561><B561><text>JP-A- 2005 512 961</text></B561><B562><text>DEBRUYNE F M J ET AL: "Ketoconazole high dose (H.D.) in advanced prostatic cancer : A comparison of two dosage regimens" JOURNAL OF STEROID BIOCHEMISTRY, PERGAMON PRESS PLC, GB, vol. 28, 1 January 1987 (1987-01-01), page 81, XP023420229 ISSN: 0022-4731 [retrieved on 1987-01-01]</text></B562><B562><text>HO A D ET AL: "Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes" LEUKEMIA RESEARCH, NEW YORK,NY, US, vol. 11, no. 11, 1 January 1987 (1987-01-01), pages 1041-1044, XP022921542 ISSN: 0145-2126 [retrieved on 1987-01-01]</text></B562><B562><text>"986 PUBLICATION Clinical study of combining arsenic trioxide (As2O3), all-trans retinoic acid (ATRA) and idarubicin (IDA) for induction therapy on the patients with relapsed acute promyelocytic leukemia(APL)" EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 3, no. 2, 1 October 2005 (2005-10-01), page 284, XP005133100 ISSN: 1359-6349</text></B562><B562><text>GANSLMAYER MARION ET AL: "The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma" JOURNAL OF HEPATOLOGY, vol. 40, no. 6, June 2004 (2004-06), pages 952-956, XP009118834 ISSN: 0168-8278</text></B562><B562><text>LEUNG MUN-FAI ET AL: "The combined differentiating effect of retinoic acid and vincristine on acute promyelocytic leukemia" LEUKEMIA RESEARCH, vol. 21, no. 1, 1997, pages 81-84, XP009118839 ISSN: 0145-2126</text></B562><B562><text>JOZAN SUZANNE ET AL: "Cytotoxic effect of interferon-alpha2a in combination with all-trans retinoic acid or cisplatin in human ovarian carcinoma cell lines" ANTI-CANCER DRUGS, vol. 9, no. 3, March 1998 (1998-03), pages 229-238, XP009118840 ISSN: 0959-4973</text></B562><B562><text>GANSLMAYER MARION ET AL: "Combined tamoxifen and retinoids affect intratumoral apoptosis rate in a rat HCC model" GASTROENTEROLOGY, vol. 126, no. 4, Suppl. 2, April 2004 (2004-04), page A597, XP009118835 &amp; DIGESTIVE DISEASE WEEK/105TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; NEW ORLEANS, LA, USA; MAY 16 20, 2004 ISSN: 0016-5085</text></B562><B562><text>CLERICI CARLO ET AL: "Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma" ANTICANCER RESEARCH, vol. 24, no. 2C, March 2004 (2004-03), pages 1255-1260, XP009118836 ISSN: 0250-7005</text></B562><B562><text>ANZANO M A ET AL: "CHEMOPREVENTION OF MAMMARY CARCINOGENESIS IN THE RAT: COMBINED USE OF RALOXIFENE AND /-CIS-RETINOIC ACID" JOURNAL OF THE NATIONAL CANCER INSTITUTE, OXFORD UNIVERSITY PRESS, GB, vol. 88, no. 2, 17 January 1996 (1996-01-17), pages 123-125, XP002054376 ISSN: 0027-8874</text></B562><B562><text>EMI N.: 'Kyusei Zen Kotsudui Kyusei Hakketsubyo ni Taisuru Shinki Chiryoho' BESSATSU IGAKU NO AYUMI 15 September 2005, pages 446 - 448, XP003017982</text></B562><B562><text>SAHARA N. ET AL.: 'Am-80, A Hissan ni yoru Kyusei Zen Kotsudui Kyusei Hakketsubyo no Chiryo' RINSHOI vol. 31, no. 12, 10 December 2005, pages 1920 - 1923, XP003017983</text></B562><B562><text>NANRI T. ET AL.: 'Kyusei Zen Kotsuduisei Hakketsubyo (Actepromyelocytic leukemia)' HEMATOLOGY &amp; ONCOLOGY vol. 52, no. 1, 28 January 2006, pages 10 - 19, XP003017984</text></B562><B562><text>KAWAKITA T. ET AL.: 'Kyusei Zen Kotsudui Kyusei Hakketsubyo Chiryo no Saikin no Hatten (Recent advances in the treatment of acute promyclocytic leukemia)' BIO CHIMICA vol. 20, no. 13, 10 December 2005, pages 1153 - 1158, XP003017985</text></B562><B562><text>YANADA M. ET AL.: '&lt;&lt;Hyojunteki Chiryoho to sono Mondaiten&gt;&gt;, Kyusei Zen Kotsuduikyusei Hakketsubyo' NAIKA vol. 92, no. 3, 01 September 2003, pages 464 - 469, XP003017986</text></B562><B562><text>KAGECHIKA H.: 'Gosei Tetinoids to sonorRinsho Oyo (Synthetic tetionoids and their clinical applications)' HEMATOLOGY &amp; ONCOLOGY vol. 51, no. 3, 28 September 2005, pages 277 - 282, XP003017987</text></B562><B562><text>TALLMAN M.S. ET AL.: 'Retinoids in Cancer Treatment' J. CLIN. PHARMACOL. vol. 32, no. 10, October 1992, pages 868 - 888, XP001000254</text></B562><B562><text>KUROKI T. ET AL.: 'Koganzei no Sayo Kiko' IWANAMI KOZA GENDAI IGAKU NO KISO 10 DAI 7 KAI HAIHON SAIBO ZOSHOKU TO GAN, KABUSHIKI KAISHA IWANAMI SHOTEN 29 June 1999, pages 199 - 212, XP003017988</text></B562><B562><text>KALEMKERIAN G.P. ET AL.: 'Activity of Fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines' CANCER CHEMOTHER. PHARMACOL. vol. 43, no. 2, February 1999, pages 145 - 150, XP002950455</text></B562><B562><text>FORMELLI F. ET AL.: 'Synthetic retinoid Fenretinide is effective against a human ovarian carcinoma xenograft and potentiates Cisplatin activity' CANCER RESEARCH vol. 53, no. 22, 15 November 1993, pages 5374 - 5376, XP008130036</text></B562><B562><text>SHUDO K. ET AL.: 'kan Shuyo Chiroyozai toshite no Gosei Retinoid Kaihatsu-TAK-101 no Kiso to Rinsho eno Tenbo (Synthetic retinoid development as hepatic tumor therapeutic agent. Basis of TAC-101 and prospect of its clinical application)' THE JOURNAL OF CLINICAL SCIENCE vol. 33, no. 6, June 1997, pages 721 - 727, XP003017990</text></B562><B565EP><date>20090703</date></B565EP></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>11184021.1</anum><pnum>2404596</pnum></dnum><date>20111005</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>EKIMOTO, Hisao</snm><adr><str>4-5, Shimo 2-chome, Kita-ku 
</str><city>Tokyo 115-0042</city><ctry>JP</ctry></adr></B721></B720><B730><B731><snm>TMRC Co., Ltd.</snm><iid>101337976</iid><irf>HMJ04516EP</irf><adr><str>Hamamatsucho OS Bldg. 
1-10-11, Hamamatsucho 
Minato-ku</str><city>Tokyo 105-0013</city><ctry>JP</ctry></adr></B731></B730><B740><B741><snm>Jones, Helen M.M.</snm><sfx>et al</sfx><iid>100027797</iid><adr><str>Gill Jennings &amp; Every LLP 
The Broadgate Tower 
20 Primrose Street</str><city>London EC2A 2ES</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>JP2007053326</anum></dnum><date>20070222</date></B861><B862>ja</B862></B860><B870><B871><dnum><pnum>WO2007108272</pnum></dnum><date>20070927</date><bnum>200739</bnum></B871></B870><B880><date>20081224</date><bnum>200852</bnum></B880></B800></SDOBI>
</ep-patent-document>
